Regulation of MafA Expression in Pancreatic β-Cells in db/db Mice With Diabetes

OBJECTIVE Islet β-cells loose their ability to synthesize insulin under diabetic conditions, which is at least partially due to the decreased activity of insulin transcription factors such as MafA. Although an in vitro study showed that reactive oxygen species (ROS) decrease MafA expression, the underlying mechanism still remains unclear. In this study, we examined the effects of c-Jun, which is known to be upregulated by ROS, on the expression of MafA under diabetic conditions. RESEARCH DESIGN AND METHODS To examine the protein levels of MafA and c-Jun, we performed histological analysis and Western blotting using diabetic db/db mice. In addition, to evaluate the possible effects of c-Jun on MafA expression, we performed adenoviral overexpression of c-Jun in the MIN6 β-cell line and freshly isolated islets. RESULTS MafA expression was markedly decreased in the islets of db/db mice, while in contrast c-Jun expression was increased. Costaining of these factors in the islets of db/db mice clearly showed that MafA and insulin levels are decreased in c-Jun–positive cells. Consistent with these results, overexpression of c-Jun significantly decreased MafA expression, accompanied by suppression of insulin expression. Importantly, MafA overexpression restored the insulin promoter activity and protein levels that were suppressed by c-Jun. These results indicate that the decreased insulin biosynthesis induced by c-Jun is principally mediated by the suppression of MafA activity. CONCLUSIONS It is likely that the augmented expression of c-Jun in diabetic islets decreases MafA expression and thereby reduces insulin biosynthesis, which is often observed in type 2 diabetes.

[1]  H. Kaneto,et al.  MafA Regulates Expression of Genes Important to Islet β-Cell Function , 2007 .

[2]  K. Kataoka,et al.  MAFA controls genes implicated in insulin biosynthesis and secretion , 2007, Diabetologia.

[3]  Yu-His Kuo,et al.  Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. , 2006, Kidney international.

[4]  J. Girault,et al.  MafA transcription factor is phosphorylated by p38 MAP kinase , 2005, FEBS letters.

[5]  J. D. Engel,et al.  MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion , 2005, Molecular and Cellular Biology.

[6]  R. Stein,et al.  Oxidative Stress-mediated, Post-translational Loss of MafA Protein as a Contributing Mechanism to Loss of Insulin Gene Expression in Glucotoxic Beta Cells* , 2005, Journal of Biological Chemistry.

[7]  Christopher J. Rhodes,et al.  Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.

[8]  T. Matsuoka,et al.  The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Kaneto,et al.  Oxidative Stress Induces Nucleo-Cytoplasmic Translocation of Pancreatic Transcription Factor PDX-1 Through Activation of c-Jun NH2-terminal Kinase , 2003 .

[10]  T. Matsuoka,et al.  Members of the Large Maf Transcription Family Regulate Insulin Gene Transcription in Islet β Cells , 2003, Molecular and Cellular Biology.

[11]  K. Kataoka,et al.  MafA Is a Glucose-regulated and Pancreatic β-Cell-specific Transcriptional Activator for the Insulin Gene* , 2002, The Journal of Biological Chemistry.

[12]  S. Bonner-Weir,et al.  Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* , 2002, The Journal of Biological Chemistry.

[13]  H. Kaneto,et al.  Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. , 2002, Diabetes research and clinical practice.

[14]  Martin Olbrot,et al.  Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Hattori,et al.  Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts) , 2002, Hypertension.

[16]  Y. Kaneda,et al.  Dominant negative c-Jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats , 2001, Gene Therapy.

[17]  A. Eychène,et al.  Phosphorylation of MafA Is Essential for Its Transcriptional and Biological Properties , 2001, Molecular and Cellular Biology.

[18]  T. Matsuoka,et al.  The DNA Binding Activity of the RIPE3b1 Transcription Factor of Insulin Appears to Be Influenced by Tyrosine Phosphorylation* , 2001, The Journal of Biological Chemistry.

[19]  V. Ferrans,et al.  Role for Mitochondrial Oxidants as Regulators of Cellular Metabolism , 2000, Molecular and Cellular Biology.

[20]  R. Stein,et al.  The RIPE3b1 Activator of the Insulin Gene Is Composed of a Protein(s) of Approximately 43 kDa, Whose DNA Binding Activity Is Inhibited by Protein Phosphatase Treatment* , 2000, The Journal of Biological Chemistry.

[21]  Y. Matsuzawa,et al.  Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. , 1999, Diabetes.

[22]  R. Robertson,et al.  Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Toyokuni,et al.  Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. , 1999, Diabetes.

[24]  L. Olson,et al.  Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. , 1998, Diabetes.

[25]  M. Tsai,et al.  Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. , 1997, Genes & development.

[26]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[27]  L. Olson,et al.  Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. , 1996, The Journal of clinical investigation.

[28]  L. Olson,et al.  The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. , 1995, Molecular endocrinology.

[29]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[30]  J. Habener,et al.  IDX‐1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. , 1994, The EMBO journal.

[31]  R. Stein,et al.  Expression of the trans-active factors that stimulate insulin control element-mediated activity appear to precede insulin gene transcription. , 1994, The Journal of biological chemistry.

[32]  R. Stein,et al.  c-jun inhibits transcriptional activation by the insulin enhancer, and the insulin control element is the target of control , 1994, Molecular and cellular biology.

[33]  H. Ohlsson,et al.  IPF1, a homeodomain‐containing transactivator of the insulin gene. , 1993, The EMBO journal.

[34]  M. Montminy,et al.  Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. , 1993, Molecular endocrinology.

[35]  E. Wagner,et al.  c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.

[36]  L. Olson,et al.  Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. , 1993, The Journal of clinical investigation.

[37]  E. Wagner,et al.  Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. , 1992, Oncogene.

[38]  S. Ishii,et al.  c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Nose,et al.  Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. , 1991, European journal of biochemistry.

[40]  M. Karin,et al.  Rapid and preferential activation of the c-jun gene during the mammalian UV response , 1991, Molecular and cellular biology.

[41]  E. Schon,et al.  RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon , 1985, Molecular and cellular biology.

[42]  H. Kaneto,et al.  MafA regulates expression of genes important to islet beta-cell function. , 2007, Molecular endocrinology.

[43]  C. Rhodes.  Type 2 diabetes-a matter of beta-cell life and death? , 2005, Science.

[44]  H. Kaneto,et al.  Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. , 2003, Diabetes.

[45]  H. Kaneto,et al.  POSSIBLE PROTECTION OF PANCREATIC ?-CELLS AGAINST GLUCOSE TOXICITY , 1999 .

[46]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.